Enveric Biosciences Correlations
ENVB Stock | USD 1.73 0.04 2.37% |
The correlation of Enveric Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Enveric Biosciences Correlation With Market
Significant diversification
The correlation between Enveric Biosciences and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Enveric |
Moving together with Enveric Stock
0.92 | EYEN | Eyenovia | PairCorr |
0.67 | MOLN | Molecular Partners | PairCorr |
0.8 | CLDX | Celldex Therapeutics | PairCorr |
0.72 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.72 | MODD | Modular Medical | PairCorr |
0.68 | APYX | Apyx Medical | PairCorr |
0.8 | SGHT | Sight Sciences | PairCorr |
0.79 | SRDX | SurModics | PairCorr |
0.64 | CNMD | CONMED | PairCorr |
Moving against Enveric Stock
0.92 | FNA | Paragon 28 | PairCorr |
0.85 | CPIX | Cumberland Pharmaceuticals | PairCorr |
0.64 | CMRX | Chimerix Sell-off Trend | PairCorr |
0.53 | OPT | Opthea | PairCorr |
0.91 | NVRO | Nevro Corp | PairCorr |
0.84 | LUCD | Lucid Diagnostics Buyout Trend | PairCorr |
0.76 | INMD | InMode | PairCorr |
0.55 | NYXH | Nyxoah | PairCorr |
0.53 | LUNG | Pulmonx Corp | PairCorr |
0.39 | MASI | Masimo | PairCorr |
0.83 | FWEDF | Fireweed Zinc | PairCorr |
0.8 | TOI | Oncology Institute Earnings Call This Week | PairCorr |
0.77 | BRK-A | Berkshire Hathaway | PairCorr |
0.77 | BRK-B | Berkshire Hathaway | PairCorr |
0.61 | TMCI | Treace Medical Concepts | PairCorr |
0.49 | TRGGF | Tarachi Gold Corp | PairCorr |
Related Correlations Analysis
0.95 | 0.59 | 0.0 | 0.0 | 0.9 | 0.0 | OCEA | ||
0.95 | 0.6 | 0.0 | 0.0 | 0.9 | 0.0 | HEPA | ||
0.59 | 0.6 | 0.0 | 0.0 | 0.54 | 0.0 | ELEV | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | AVRO | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | CWBR | ||
0.9 | 0.9 | 0.54 | 0.0 | 0.0 | 0.0 | ZURA | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | EFTR | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Enveric Stock performing well and Enveric Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Enveric Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
OCEA | 7.10 | (3.01) | 0.00 | (2.02) | 0.00 | 15.38 | 51.00 | |||
HEPA | 9.95 | (3.85) | 0.00 | (5.52) | 0.00 | 16.37 | 90.05 | |||
ELEV | 4.43 | (0.32) | 0.00 | (0.29) | 0.00 | 8.33 | 40.61 | |||
AVRO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CWBR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ZURA | 4.83 | (0.48) | 0.00 | (0.27) | 0.00 | 9.79 | 29.06 | |||
EFTR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Enveric Biosciences Corporate Management
Joseph Tucker | CEO Director | Profile | |
Ibrahim MD | Chief Officer | Profile | |
MBA IV | Interim Officer | Profile | |
Peter Facchini | Chief Officer | Profile | |
Avani Kanubaddi | Pres COO | Profile | |
Kevin CPA | Chief Officer | Profile |